Found: 11
Select item for more details and to access through your institution.
Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 2, p. 265, doi. 10.1093/jac/dkq458
- By:
- Publication type:
- Article
Sequential treatment with 5-aza-2′-deoxycytidine and deacetylase inhibitors reactivates HIV-1.
- Published in:
- EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 117, doi. 10.15252/emmm.201505557
- By:
- Publication type:
- Article
Limited HIV-1 Reactivation in Resting CD4<sup>+</sup> T cells from Aviremic Patients under Protease Inhibitors.
- Published in:
- Scientific Reports, 2016, p. 38313, doi. 10.1038/srep38313
- By:
- Publication type:
- Article
Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line.
- Published in:
- Scientific Reports, 2016, p. 24090, doi. 10.1038/srep24090
- By:
- Publication type:
- Article
Comparison of Methods for In-House Screening of HLA-B*57:01 to Prevent Abacavir Hypersensitivity in HIV-1 Care.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0123525
- By:
- Publication type:
- Article
Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection.
- Published in:
- PLoS ONE, 2009, v. 4, n. 6, p. 1, doi. 10.1371/journal.pone.0006093
- By:
- Publication type:
- Article
Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, n. 10, p. 1582, doi. 10.1093/cid/civ587
- By:
- Publication type:
- Article
Raltegravir in HIV-1-Infected Pregnant Women: Pharmacokinetics, Safety, and Efficacy.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, n. 5, p. 809, doi. 10.1093/cid/civ366
- By:
- Publication type:
- Article
An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 7, p. 1, doi. 10.1371/journal.ppat.1005063
- By:
- Publication type:
- Article
Pharmacokinetics of total and unbound darunavir in HIV-1-infected pregnant women.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
HIV-1 V3 envelope deep sequencing forclinical plasma specimens failing inphenotypic tropism assays.
- Published in:
- AIDS Research & Therapy, 2010, v. 7, p. 4, doi. 10.1186/1742-6405-7-4
- By:
- Publication type:
- Article